A197

· Aramis Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A197, covering 2023-05-16 to 2023-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease [Phase 2]